Allogeneic and Autologous Anti-CD7 CAR-T Cell Therapies in Relapsed or Refractory T Cell Malignancies

被引：2
|
作者：
Zhang, Yinqiang [1 ,2 ]
Li, Chenggong [1 ,2 ]
Jiang, Huiwen [1 ,2 ]
Luo, Wenjing [1 ,2 ]
Du, Mengyi [1 ,2 ]
Zhou, Fen [1 ,3 ]
Tang, Lu [1 ,2 ]
Wu, Jianghua [1 ,2 ]
Wei, Qiuzhe [1 ,2 ]
Lu, Cong [1 ,2 ]
Kou, Haiming [1 ,2 ]
Wu, Di [4 ]
Alex, Chang H. [5 ]
Mei, Heng [1 ,2 ]
Hu, Yu [1 ,2 ]
机构：
[1] Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Peoples R China
[4] Beijing GoBrd Hosp Management Co Ltd, Beijing, Peoples R China
[5] Shanghai YaKe Biotechnol Ltd, Shanghai, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170819
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4592 / 4594
页数：3
相关论文
共 50 条
  • [21] Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study
    Hu, Yongxian
    Zhou, Yali
    Zhang, Mingming
    Zhao, Houli
    Wei, Guoqing
    Ge, Wengang
    Cui, Qu
    Mu, Qitian
    Chen, Gong
    Han, Lu
    Guo, Tingting
    Cui, Jiazhen
    Jiang, Xiaoyan
    Zheng, Xiujun
    Yu, Shuhui
    Li, Xiaolong
    Zhang, Xingwang
    Chen, Mingxi
    Li, Xiuju
    Gao, Ming
    Wang, Kang
    Zu, Cheng
    Zhang, Hao
    He, Xiaohong
    Wang, Yanbin
    Wang, Dongrui
    Ren, Jiangtao
    Huang, He
    CELL RESEARCH, 2022, 32 (11) : 995 - 1007
  • [22] CAR-T Cell Therapy for T-Cell Malignancies
    Testa, Ugo
    Chiusolo, Patrizia
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [23] Safety and efficacy of autologous and allogeneic humanized CD19-targeted CAR-T cell therapy for patients with relapsed/refractory B-ALL
    Song, Fengmei
    Hu, Yongxian
    Zhang, Yanlei
    Zhang, Mingming
    Yang, Tingting
    Wu, Wenjun
    Huang, Simao
    Xu, Huijun
    Chang, Alex H.
    Huang, He
    Wei, Guoqing
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (02)
  • [24] Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study
    Yongxian Hu
    Yali Zhou
    Mingming Zhang
    Houli Zhao
    Guoqing Wei
    Wengang Ge
    Qu Cui
    Qitian Mu
    Gong Chen
    Lu Han
    Tingting Guo
    Jiazhen Cui
    Xiaoyan Jiang
    Xiujun Zheng
    Shuhui Yu
    Xiaolong Li
    Xingwang Zhang
    Mingxi Chen
    Xiuju Li
    Ming Gao
    Kang Wang
    Cheng Zu
    Hao Zhang
    Xiaohong He
    Yanbin Wang
    Dongrui Wang
    Jiangtao Ren
    He Huang
    Cell Research, 2022, 32 : 995 - 1007
  • [25] Subsequent Secondary CAR-T Cell Therapy Was Superior to Chemotherapy in Patients with Refractory/Relapsed BCell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy
    Yang, Fan
    Liu, Rui
    Xu, Teng
    Zheng, Peihao
    Feng, Shaomei
    Guo, Yuelu
    Ma, Lixia
    Shi, Hui
    Deng, Biping
    Ke, Xiaoyan
    Wu, Tong
    Hu, Kai
    BLOOD, 2022, 140 : 10384 - 10385
  • [26] A Novel Universal CD7-Targeted CAR-T Cell Therapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma
    Zhang, Xian
    Zhou, Yali
    Yang, Junfang
    Li, Jingjing
    Qiu, Liyuan
    Ge, Wengang
    Pei, Bo
    Chen, Jie
    Han, Lu
    Ren, Jiangtao
    Lu, Peihua
    BLOOD, 2022, 140 : 4566 - 4567
  • [27] Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
    Shahid, Sanam
    Prockop, Susan E.
    Flynn, Georgia C.
    Mauguen, Audrey
    White, Charlie O.
    Bieler, Jennifer
    Mcavoy, Devin
    Hosszu, Kinga
    Cancio, Maria I.
    Jakubowski, Ann A.
    Scaradavou, Andromachi
    Boelens, Jaap Jan
    Sauter, Craig S.
    Perales, Miguel-Angel
    Giralt, Sergio A.
    Taylor, Clare
    Chaudhari, Jagrutiben
    Wang, Xiuyan
    Riviere, Isabelle
    Sadelain, Michel
    Brentjens, Renier J.
    Kernan, Nancy A.
    O'Reilly, Richard J.
    Curran, Kevin J.
    BLOOD ADVANCES, 2025, 9 (07) : 1644 - 1657
  • [28] CAR-T cell therapy bridging to allogeneic hematopoietic cell transplantation for patients with refractory and relapsed acute lymphoblastic leukemia
    Chen, Jia
    Fan, Yi
    Xu, Yang
    Chen, Suning
    Qiu, Huiying
    Tang, Xiaowen
    Han, Yue
    Fu, Cheng-cheng
    Wu, Depei
    BONE MARROW TRANSPLANTATION, 2019, 54 : 124 - 124
  • [29] Pseudo-Allogeneic CAR-T Therapy after Allogeneic Stem Cell Transplantation in Relapsed/Refractory B-Cell NHL
    Siglin, Jonathan
    Lutfi, Forat
    Bukhari, Ali
    Holtzman, Noa G.
    Kim, Dong Won
    Ali, Moaath Mustafa
    Rapoport, Aaron P.
    Dahiya, Saurabh
    BLOOD, 2020, 136
  • [30] T cell senescence and CAR-T cell exhaustion in hematological malignancies
    Kasakovski, Dimitri
    Xu, Ling
    Li, Yangqiu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
12345